Explore as a

Share our content


View recipients of the Hercus Medal.

Latest recipient

The 2018 Hercus Medal was awarded to Professor Brett Delahunt ONZM KStJ FRSNZ for his internationally recognised contributions as a pathologist, especially in relation to kidney and prostate cancer.

Previous recipients


Professor Richard Beasley FRSNZ (for his significant contribution to the advancement of respiratory medicine and health science research in New Zealand)


Parry Guilford FRSNZ (for his work that established the gene mutation that can lead to hereditary stomach cancer in families)


John Fraser FRSNZ (for his pioneering studies on bacterial superantigens which have major implications for understanding and treating human infectious diseases)


Alistair Gunn FRSNZ (for his exceptional contribution to perinatal physiology and clinical medicine both as a research scientist making breakthrough discoveries and as a research leader who is able to turn his research discoveries into clinically successful outcomes for babies


Mark Richards FRSNZ (for his cardiovascular research for more than 30 years. Mark is one of the leading clinical scientists in the broad area of translational cardiovascular biology and medicine)


Bruce Charles Baguley FRSNZ (for his significant contribution to the development of new cancer therapeutics)


Joel Ivor Mann FRSNZ – for his extended series of related studies of nutrition in relation to diabetes and cardiovascular disease


No award


David Anthony Dougall Parry FRSNZ (for his extended series of related studies of the chemistry, physics, biochemistry, ultratructure, and biological function of fibrous proteins)


David Christopher Graham Skegg FRSNZ (for consistently maintaining the highest standards in public health science and policy)


Peter David Gluckman FRSNZ (for his pioneering work on the physiology of fetal growth and maturation, and the origins of brain injury at birth)


Anthony Edmund Reeve FRSNZ (for research into applying DNA technology to develop an understanding of the genomic changes that lead to the onset of cancer)